Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in candida spp. and aspergillus spp. to amphotericin B and echinocandins for the etest agar diffusion method

Identificadores
URI: http://hdl.handle.net/10498/36673
DOI: 10.1128/AAC.01792-16
ISSN: 1098-6596
ISSN: 0066-4804
Statistics
Metrics and citations
Metadata
Show full item recordAuthor/s
Espinel Ingroff, A.; Arendrup, M.; Canton, E.; Cordob, S.; Dannaoui, E.; García Rodríguez, J.; González, G.M.; Govender, N.P.; Martín Mazuelos, E.; Lackner, M.; Lass-Florl, C.; Linares Sicilia, M.J.; Rodríguez Iglesias, Manuel Antonio
; Peláez, T.; Shields, R.K.; García Effron, G.; Guinea, J.; Sanguinetti, M.; Turnidger, J.
Date
2017Department
Biomedicina, Biotecnología y Salud PúblicaSource
Antimicrobial Agents and Chemotherapy - 2017, Vol. 61 n. 1 pp. 1-10Abstract
Method-dependent Etest epidemiological cutoff values (ECVs) are not available for susceptibility testing of either Candida or Aspergillus species with amphotericin B or echinocandins. In addition, reference caspofungin MICs for Candida spp. are unreliable. Candida and Aspergillus species wild-type (WT) Etest MIC distributions (microorganisms in a species-drug combination with no detectable phenotypic resistance) were established for 4,341 Candida albicans, 113 C. dubliniensis, 1,683 C. glabrata species complex (SC), 709 C. krusei, 767 C. parapsilosis SC, 796 C. tropicalis, 1,637 Aspergillus fumigatus SC, 238 A. flavus SC, 321 A. Niger SC, and 247 A. terreus SC isolates. Etest MICs from 15 laboratories (in Argentina, Europe, Mexico, South Africa, and the United States) were pooled to establish Etest ECVs. Anidulafungin, caspofungin, micafungin, and amphotericin B ECVs (in micrograms per milliliter) encompassing ≥97.5% of the statistically modeled population were 0.016, 0.5, 0.03, and 1 for C. albicans; 0.03, 1, 0.03, and 2 for C. glabrata SC; 0.06, 1, 0.25, and 4 for C. krusei; 8, 4, 2, and 2 for C. parapsilosis SC; and 0.03, 1, 0.12, and 2 for C. tropicalis. The amphotericin B ECV was 0.25 μg/ml for C. dubliniensis and 2, 8, 2, and 16 μg/ml for the complexes of A. fumigatus, A. flavus, A. Niger, and A. terreus, respectively. While anidulafungin Etest ECVs classified 92% of the Candida fks mutants evaluated as non-WT, the performance was lower for caspofungin (75%) and micafungin (84%) cutoffs. Finally, although anidulafungin (as an echinocandin surrogate susceptibility marker) and amphotericin B ECVs should identify Candida and Aspergillus isolates with reduced susceptibility to these agents using the Etest, these ECVs will not categorize a fungal isolate as susceptible or resistant, as breakpoints do.
Subjects
ECVs; Etest ECVs; Etest MICs Candida; Etest MICs Aspergillus; WT isolates; amphotericin B resistance; antifungal resistance; echinocandin resistance; non-WT; susceptibility markerCollections
- Artículos Científicos [11977]
- Articulos Científicos Biomedicina [582]
- Artículos Científicos INIBICA [1093]





